Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)

Market Cap	3.43B -28.8%
Revenue (ttm)	1.01B +24.1%
Net Income	-632.73M
EPS	-3.31
Shares Out	191.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,379,838
Open	18.13
Previous Close	18.14
Day's Range	17.71 - 18.29
52-Week Range	17.03 - 28.99
Beta	0.82
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHA:688298

Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products in China and internationally. Its products include POCT instant diagnostic reagents that are used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company also offers human and animal health products; and raw materials for rapid testing, fluorescent immunoassay, western blot, biochemistry, and molecular diagnostics. It serves pharmacies chain, supermarkets, tertiary hospi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 2,068
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688298

Financial Performance

In 2025, SHA:688298's revenue was 947.38 million, an increase of 14.43% compared to the previous year's 827.92 million. Losses were -573.60 million, 8.43% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 19, 2026

Data Sources Report a data error